[go: up one dir, main page]

DK356085A - Reninhaemmende peptid eller et farmaceutisk acceptabelt syreadditionssalt deraf - Google Patents

Reninhaemmende peptid eller et farmaceutisk acceptabelt syreadditionssalt deraf Download PDF

Info

Publication number
DK356085A
DK356085A DK356085A DK356085A DK356085A DK 356085 A DK356085 A DK 356085A DK 356085 A DK356085 A DK 356085A DK 356085 A DK356085 A DK 356085A DK 356085 A DK356085 A DK 356085A
Authority
DK
Denmark
Prior art keywords
acid addition
addition salt
acceptable acid
pharmaceutical acceptable
inhibition
Prior art date
Application number
DK356085A
Other languages
English (en)
Other versions
DK356085D0 (da
Inventor
Jr Jackson Boling Hester
Donald Theodore Pals
Hossain Hassain Saneii
Tomi Kim Sawyer
Heinrich Josef Schostarez
Ruth Elizabeth Tenbrink
Suvit Thaisrivongs
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of DK356085D0 publication Critical patent/DK356085D0/da
Publication of DK356085A publication Critical patent/DK356085A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96472—Aspartic endopeptidases (3.4.23)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Furan Compounds (AREA)
DK356085A 1984-08-06 1985-08-05 Reninhaemmende peptid eller et farmaceutisk acceptabelt syreadditionssalt deraf DK356085A (da)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US63804184A 1984-08-06 1984-08-06
US63802584A 1984-08-06 1984-08-06
US63802784A 1984-08-06 1984-08-06
US63802384A 1984-08-06 1984-08-06
US66302684A 1984-10-19 1984-10-19
US66309384A 1984-10-19 1984-10-19
US66302784A 1984-10-19 1984-10-19
US66302884A 1984-10-19 1984-10-19
US75319885A 1985-07-09 1985-07-09

Publications (2)

Publication Number Publication Date
DK356085D0 DK356085D0 (da) 1985-08-05
DK356085A true DK356085A (da) 1986-02-07

Family

ID=27578888

Family Applications (1)

Application Number Title Priority Date Filing Date
DK356085A DK356085A (da) 1984-08-06 1985-08-05 Reninhaemmende peptid eller et farmaceutisk acceptabelt syreadditionssalt deraf

Country Status (4)

Country Link
EP (2) EP0486478A3 (da)
JP (2) JPH0643410B2 (da)
DK (1) DK356085A (da)
FI (1) FI88400C (da)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613676A (en) * 1983-11-23 1986-09-23 Ciba-Geigy Corporation Substituted 5-amino-4-hydroxyvaleryl derivatives
JPS60163899A (ja) * 1984-02-03 1985-08-26 Sankyo Co Ltd レニン阻害ペプチド類
EP0181110A3 (en) * 1984-10-22 1988-05-11 Kissei Pharmaceutical Co. Ltd. Histidine derivatives as renin inhibitors
US4727060A (en) * 1984-11-13 1988-02-23 Ciba-Geigy Corporation Novel 5-amino-4-hydroxyvaleryl derivatives
EP0190891A3 (en) * 1985-01-31 1988-04-20 Kissei Pharmaceutical Co. Ltd. Novel amino acid derivatives
DE3674131D1 (de) 1985-04-19 1990-10-18 Upjohn Co Substituierte dihalo-statin-reninhemmungsmittel.
US4882420A (en) * 1985-04-19 1989-11-21 The Upjohn Company Dihalo-statine substituted renin inhibitors
EP0206807A3 (en) * 1985-06-28 1988-01-20 Kissei Pharmaceutical Co. Ltd. Novel amino acid derivatives
CA1290097C (en) * 1985-07-24 1991-10-01 Merck & Co., Inc. Peptide enzyme inhibitors
US4729985A (en) * 1985-08-09 1988-03-08 Pfizer Inc. Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues
US4853463A (en) * 1985-09-04 1989-08-01 Kissei Pharmaceutical Co., Ltd. Amino acid derivatives
US4894437A (en) * 1985-11-15 1990-01-16 The Upjohn Company Novel renin inhibiting polypeptide analogs containing S-aryl-D- or L- or DL-cysteinyl, 3-(arylthio)lactic acid or 3-(arylthio)alkyl moieties
EP0245361A1 (en) * 1985-11-15 1987-11-19 The Upjohn Company Novel renin inhibiting polypeptide analogs containing s-aryl-d- or l- or dl-cysteinyl, 3-(arylthio)lactic acid or 3-(arylthio)alkyl moieties
NZ218937A (en) * 1986-01-16 1990-03-27 Abbott Lab Functionalised peptidyl aminodiols and -triols as renin inhibitors and pharmaceutical compositions
EP0236734A3 (de) * 1986-02-07 1988-05-11 Ciba-Geigy Ag Durch schwefelhaltigen Gruppen substituierte 5-Amino-4-hydroxyvalerylderivate
CA1309555C (en) * 1986-02-27 1992-10-27 Suvit Thaisrivongs Inhibiting peptides having a dihydroxyethylene isostere transitionstate insert
US4705846A (en) * 1986-03-27 1987-11-10 The Upjohn Company Novel renin inhibiting peptides having a gamma lactam pseudo dipeptide insert
DE3610593A1 (de) * 1986-03-29 1987-10-01 Hoechst Ag Substituierte 4-amino-3-hydroxybuttersaeure-derivate verfahren zu deren herstellung, diese enthaltende mittel und ihre verwendung
ES2066755T3 (es) * 1986-06-10 1995-03-16 Merck Patent Gmbh Derivados de aminoacidos inhibidores de renina.
JPS6322081A (ja) * 1986-07-11 1988-01-29 Kissei Pharmaceut Co Ltd 新規なアミノ酸誘導体
DE3627877A1 (de) * 1986-07-30 1988-02-04 Hoechst Ag Renin-hemmende di- und tripeptide, verfahren zu deren herstellung, diese enthaltende mittel und ihre verwendung
GB8619182D0 (en) * 1986-08-06 1986-09-17 Sandoz Ltd Peptides & derivatives
ES2053582T3 (es) * 1986-08-13 1994-08-01 Ciba Geigy Ag Procedimiento para la obtencion de derivados del acido 5-amino-4-hidroxivalerianico.
WO1988002374A2 (en) * 1986-09-30 1988-04-07 The Upjohn Company Renin inhibitory peptides having novel c-terminal moieties
US4851387A (en) * 1986-10-14 1989-07-25 Banyu Pharmaceutical Co., Ltd. 5-substituted amino-4-hydroxy-pentanoic acid derivatives and their use
EP0278158A3 (en) * 1986-11-12 1990-05-23 Merck & Co. Inc. Renin inhibitors containing phenylalanyl-histidine replacements
US4743585A (en) * 1986-11-21 1988-05-10 Warner-Lambert Company Renin inhibitors
US4895834A (en) * 1986-12-15 1990-01-23 Warner-Lambert Company Renin inhibitors III
JPH02501140A (ja) * 1986-12-22 1990-04-19 ジ・アップジョン・カンパニー エポキシドまたはグリコール基を有するレニン‐抑制ペプチド
SE8605573D0 (sv) * 1986-12-29 1986-12-29 Haessle Ab Novel compounds
US5032577A (en) * 1986-12-31 1991-07-16 Abbott Laboratories Peptidylaminodiols
NL8800100A (nl) * 1987-01-21 1988-08-16 Sandoz Ag Nieuwe peptidederivaten en werkwijzen voor het bereiden en toepassen van deze derivaten.
US4758584A (en) * 1987-02-05 1988-07-19 Ciba-Geigy Corporation Antihypertensive 5-amino-4-hydroxyvaleryl derivatives substituted by sulphur-containing groups
EP0349570A1 (en) * 1987-03-09 1990-01-10 The Upjohn Company Renin inhibitors containing a cyclopropyl amino acid and/or a cycloalkyl transition-state analogue
AU2123288A (en) * 1987-08-07 1989-03-09 Upjohn Company, The Renin inhibiting peptides with nonpeptide linkages
WO1989003842A1 (en) * 1987-10-21 1989-05-05 The Upjohn Company Renin inhibitors containing a (1-amino-2-hydroxy-2-heterocyclic) ethyl moiety
GB8728560D0 (en) * 1987-12-07 1988-01-13 Glaxo Group Ltd Chemical compounds
GB8728561D0 (en) * 1987-12-07 1988-01-13 Glaxo Group Ltd Chemical compounds
ATE107658T1 (de) * 1988-01-26 1994-07-15 Sankyo Co Renin inhibierende polypeptide, ihre herstellung und anwendung.
JPH03502328A (ja) * 1988-02-01 1991-05-30 ジ・アップジョン・カンパニー 極性末端基類を有するレニン抑制ペプチド類
US4981843A (en) * 1988-04-07 1991-01-01 E. R. Squibb & Sons, Inc. N-heterocyclic alcohol derivatives
EP0413750A1 (en) * 1988-05-03 1991-02-27 The Upjohn Company Renin inhibitory peptides containing a substituted phenoxyacetyle group
DE3815913A1 (de) * 1988-05-10 1989-11-23 Sandoz Ag Neue reninhemmer, verfahren zu deren herstellung und deren verwendung
EP0347987A3 (en) * 1988-06-20 1991-01-02 Merck & Co. Inc. Tripeptide renin inhibitors with n-terminal carbamoyl or acyl groups
US5175298A (en) * 1988-06-30 1992-12-29 The Upjohn Company Dipeptide hydroxy ethylene isostere synthesis and intermediates therefor
EP0423170A1 (en) * 1988-06-30 1991-04-24 The Upjohn Company Dipeptide hydroxy ethylene isostere synthesis and intermediates therefor
EP0449943A1 (en) * 1988-12-22 1991-10-09 The Upjohn Company Transdermal and intranasal administration of renin inhibitory peptides
AU4665289A (en) * 1988-12-22 1990-07-10 Upjohn Company, The N-alkylation of n-alpha-boc-protected amino acids
US5342981A (en) * 1991-03-06 1994-08-30 Abbott Laboratories Substantially isomerically pure hexane or hexene compounds
US5229518A (en) * 1991-03-06 1993-07-20 Abbott Laboratories Isomerically pure 2-piperidone compounds
US5643878A (en) * 1991-09-12 1997-07-01 Ciba-Geigy Corporation 5-amino-4-hydroxyhexanoic acid derivatives
US5413999A (en) * 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
TW217410B (da) * 1992-04-01 1993-12-11 Ciba Geigy
US5559256A (en) * 1992-07-20 1996-09-24 E. R. Squibb & Sons, Inc. Aminediol protease inhibitors
JP3409439B2 (ja) * 1994-06-17 2003-05-26 日産自動車株式会社 左右輪と前後輪の駆動力配分総合制御装置
US6486193B2 (en) 1998-12-31 2002-11-26 Aventis Pharmaceuticals Inc. 3-substituted pyrrolidines useful as inhibitors of matrix metalloproteinases
UA108742C2 (uk) 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO812612L (no) * 1980-08-06 1982-02-08 Ferring Pharma Ltd Enzym-inhibitorer.
CA1258748A (en) * 1981-10-08 1989-08-22 Daniel F. Veber Renin inhibitory peptides
JPS5865260A (ja) * 1981-10-13 1983-04-18 Microbial Chem Res Found ３−アミノ−２−ヒドロキシ−４−フエニル酪酸誘導体および医薬組成物
DE3377497D1 (en) * 1982-09-15 1988-09-01 Haessle Ab Enzyme inhibitors
FI843837L (fi) * 1983-02-07 1984-09-28 Ferring Ab Enzyminhibitorer.
EP0144290A3 (de) * 1983-12-01 1987-05-27 Ciba-Geigy Ag Substituierte Aethylendiaminderivate
US4727060A (en) * 1984-11-13 1988-02-23 Ciba-Geigy Corporation Novel 5-amino-4-hydroxyvaleryl derivatives
DE3674131D1 (de) * 1985-04-19 1990-10-18 Upjohn Co Substituierte dihalo-statin-reninhemmungsmittel.

Also Published As

Publication number Publication date
EP0486478A2 (en) 1992-05-20
JPH05222063A (ja) 1993-08-31
FI853004A0 (fi) 1985-08-05
FI88400C (fi) 1993-05-10
EP0173481A2 (en) 1986-03-05
JPH0643410B2 (ja) 1994-06-08
JPH05194462A (ja) 1993-08-03
FI88400B (fi) 1993-01-29
EP0173481A3 (en) 1988-12-21
DK356085D0 (da) 1985-08-05
EP0486478A3 (en) 1992-08-12
FI853004L (fi) 1986-02-07

Similar Documents

Publication Publication Date Title
DK356085A (da) Reninhaemmende peptid eller et farmaceutisk acceptabelt syreadditionssalt deraf
DK340088D0 (da) Aminosyrederivater
FI864964L (fi) Molekyler anvaendbara vid detektering av nukleinsyrasekvenser.
IT1199838B (it) Metodi per la preparazione di medicazioni
DK30886D0 (da) Peptidderivater
KR870700608A (ko) 아미노-살리실산 유도체 및 제약 조성물
DK686487D0 (da) 1h-imidazol-5-carboxylsyrederivater
IT1214683B (it) Composizioni farmaceutiche nasali
FI860878L (fi) Aminosyraderivat och foerfarande foer deras framstaellning.
DK101287A (da) 1h-imidazol-5-carboxylsyrederivater
DK523288D0 (da) Aminosyrederivater
DK655487A (da) Furanuronsyrederivater
DK314386D0 (da) Quinoloncarboxyylsyreforbindelse og antibakterielle farmaceutiske praeparater indeholdende denne
DK340485D0 (da) Phenylnonatetraensyrederivater
DK99085D0 (da) Farmaceutiske praeparater indeholdende a-vitaminsyrederivater
DK160299C (da) Basiske 2-fenylenmetylen-cykloalkanoximaetere eller farmaceutisk acceptable syreadditionssalte deraf samt farmaceutiske praeparater indeholdende saadanne forbindelser
DK317985A (da) Aminoeburnancarboxylsyrederivater
DK318085D0 (da) Nitroapovincaminsyrederivater
DK576687A (da) Terapeutisk aktive alkensyrederivater
IT1200467B (it) Formulazione farmaceutica
DK694987D0 (da) 1-cyclyl- eller polycyclylsubstituerede 1h-imidazol-5-carboxylsyrer
DK527486A (da) Substituerede 1-amino-cyclopropancarboxylsyrederivater
IT1222142B (it) Composizioni farmaceutiche antivirali
DK403987A (da) Benzohydroxamsyrederivater
DK488687A (da) N-alkylbenzensulfonamider eller et farmaceutisk acceptabelt salt deraf

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment